Tag
3 articles
Novo Nordisk and AWS have partnered to integrate agentic AI into drug discovery, aiming to accelerate the development of new therapies through advanced AI tools and a co-innovation hub in London.
Novo Holdings, the investment firm behind Novo Nordisk, is backing a new fund to support Italian drug startups, extending its investment reach beyond Denmark.
Novo Nordisk has handed over its discontinued Parkinson’s therapy STEM-PD to AI biotech startup Cellular Intelligence, in a deal that includes equity stakes and future milestone payments.
